Question 1

Is Hepatitis-B-Surface-Antigen-Recombinant currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Hepatitis-B-Surface-Antigen-Recombinant has 1 active shortage notice across 1 country (Australia). Status is refreshed daily from official regulatory sources.

Question 2

Why is Hepatitis-B-Surface-Antigen-Recombinant in shortage?

Accepted Answer

Regulators attribute the current Hepatitis-B-Surface-Antigen-Recombinant shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Hepatitis-B-Surface-Antigen-Recombinant shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 31 May 2026 to 31 May 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Hepatitis-B-Surface-Antigen-Recombinant shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Hepatitis-B-Surface-Antigen-Recombinant shortage status

Where Hepatitis-B-Surface-Antigen-Recombinant is in shortage

Why Hepatitis-B-Surface-Antigen-Recombinant is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Hepatitis-B-Surface-Antigen-Recombinant status changes